eli lilly phase 3 trial retatrutide said Thursday its experimental obesity drug delivered up to 28.3 percent body-weight reduction over 80 weeks in the pivotal TRIUMPH-1 trial, a result nearing the weight-loss range Retatrutide Shows 28% Weight Loss

Research from obesity pharmacotherapy trials consistently shows that higher protein intake (targeting 0.8-1.0 grams per pound of goal body weight daily) significantly improves lean mass retention during rapid weight loss

How Much Does Mounjaro Cost Per Month in the UK

Tesamorelin addresses what many weight loss peptide approaches miss entirely: the deep abdominal fat that drives metabolic syndrome

It is FDA-approved, uses SNAC absorption technology, and rides on the same clinical evidence base as injectable Wegovy

That kind of transparency mattered to me

Avoid hot, greasy, or strongly flavored foods on nausea days